BACKGROUND: Increasing evidence points to a direct role for altered microRNA (miRNA or miR) expression levels in cardiovascular remodeling and disease progression. Although alterations in miR expression levels have been directly linked to cardiac hypertrophy, fibrosis, and remodeling, their role in regulating gene expression during thoracic aortic aneurysm (TAA) development has yet to be explored. METHODS AND RESULTS: The present study examined miR expression levels in aortic tissue specimens collected from patients with ascending TAAs by quantitative real-time PCR, and observed decreased miR expression (miRs -1, -21, -29a, -133a, and -486) as compared with normal aortic specimens. A significant relationship between miR expression levels (miRs -1, -21, -29a, and -133a) and aortic diameter was identified; as aortic diameter increased, miR expression decreased. Through the use of a bioinformatics approach, members of the matrix metalloproteinase (MMP) family, proteins involved in TAA development, were examined for putative miR binding sites. MMP-2 and MMP-9 were identified as potential targets for miR-29a and miR-133a, respectively, and MMP-2 was subsequently verified as a miR-29a target in vitro. A significant inverse relationship between miR-29a and total MMP-2 was then identified in the clinical TAA specimens. CONCLUSIONS: These findings demonstrate altered miR expression patterns in clinical TAA specimens, suggesting that the loss of specific miR expression may allow for the elaboration of specific MMPs capable of driving aortic remodeling during TAA development. Importantly, these data suggest that these miRs have biological and clinical relevance to the behavior of TAAs and may provide significant targets for therapeutic and diagnostic applications.
BACKGROUND: Increasing evidence points to a direct role for altered microRNA (miRNA or miR) expression levels in cardiovascular remodeling and disease progression. Although alterations in miR expression levels have been directly linked to cardiac hypertrophy, fibrosis, and remodeling, their role in regulating gene expression during thoracic aortic aneurysm (TAA) development has yet to be explored. METHODS AND RESULTS: The present study examined miR expression levels in aortic tissue specimens collected from patients with ascending TAAs by quantitative real-time PCR, and observed decreased miR expression (miRs -1, -21, -29a, -133a, and -486) as compared with normal aortic specimens. A significant relationship between miR expression levels (miRs -1, -21, -29a, and -133a) and aortic diameter was identified; as aortic diameter increased, miR expression decreased. Through the use of a bioinformatics approach, members of the matrix metalloproteinase (MMP) family, proteins involved in TAA development, were examined for putative miR binding sites. MMP-2 and MMP-9 were identified as potential targets for miR-29a and miR-133a, respectively, and MMP-2 was subsequently verified as a miR-29a target in vitro. A significant inverse relationship between miR-29a and total MMP-2 was then identified in the clinical TAA specimens. CONCLUSIONS: These findings demonstrate altered miR expression patterns in clinical TAA specimens, suggesting that the loss of specific miR expression may allow for the elaboration of specific MMPs capable of driving aortic remodeling during TAA development. Importantly, these data suggest that these miRs have biological and clinical relevance to the behavior of TAAs and may provide significant targets for therapeutic and diagnostic applications.
Authors: Scott A LeMaire; Xinwen Wang; Jonathan A Wilks; Stacey A Carter; Shixiang Wen; Taehee Won; Dominic Leonardelli; Gobind Anand; Lori D Conklin; Xing Li Wang; Robert W Thompson; Joseph S Coselli Journal: J Surg Res Date: 2005-01 Impact factor: 2.192
Authors: Jeffrey A Jones; John R Barbour; Abigail S Lowry; Shenikqua Bouges; Christy Beck; David M McClister; Rupak Mukherjee; John S Ikonomidis Journal: J Vasc Surg Date: 2006-12 Impact factor: 4.268
Authors: Jeffrey A Jones; Jean Marie Ruddy; Shenikqua Bouges; Juozas A Zavadzkas; Theresa A Brinsa; Robert E Stroud; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis Journal: Am J Physiol Heart Circ Physiol Date: 2010-04-23 Impact factor: 4.733
Authors: Jon Boyum; Erika K Fellinger; Joseph D Schmoker; Lucy Trombley; Kenneth McPartland; Frank P Ittleman; Alan B Howard Journal: J Thorac Cardiovasc Surg Date: 2004-03 Impact factor: 5.209
Authors: Luciano F Borges; Ziad Touat; Anne Leclercq; Ayman Al Haj Zen; Guillaume Jondeau'; Brigitte Franc; Monique Philippe; Olivier Meilhac; Paulo S Gutierrez; Jean-Baptiste Michel Journal: Hum Pathol Date: 2008-10-29 Impact factor: 3.466
Authors: Stefanie S Portelli; Elizabeth N Robertson; Cassandra Malecki; Kiersten A Liddy; Brett D Hambly; Richmond W Jeremy Journal: Biophys Rev Date: 2018-09-28
Authors: John S Ikonomidis; Charlotte R Ivey; Jason B Wheeler; Adam W Akerman; Allison Rice; Risha K Patel; Robert E Stroud; Asad A Shah; Chad G Hughes; Giovanni Ferrari; Rupak Mukherjee; Jeffrey A Jones Journal: J Thorac Cardiovasc Surg Date: 2013-01-11 Impact factor: 5.209